wb.md
RSV Antibody Levels Tied to Posttransplant Infection Risk
After hematopoietic cell transplant, sirolimus use for GVHD prophylaxis is linked to a higher RSV risk, whereas higher serum neutralizing antibody levels are tied to a lower risk within 100 days.